🇪🇺 therapeutic testosterone in European Union

EMA authorised therapeutic testosterone on 28 July 2006

Marketing authorisation

EMA — authorised 28 July 2006

  • Application: EMEA/H/C/000630
  • Marketing authorisation holder: Warner Chilcott  Deutschland GmbH
  • Local brand name: Livensa
  • Indication: Livensa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.
  • Status: withdrawn

Read official source →

therapeutic testosterone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is therapeutic testosterone approved in European Union?

Yes. EMA authorised it on 28 July 2006.

Who is the marketing authorisation holder for therapeutic testosterone in European Union?

Warner Chilcott  Deutschland GmbH holds the EU marketing authorisation.